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Abstract
Background: Lime extracts of  powdered combination of  seeds of  Picralima nitida, stem bark of  Alstonia boonei and 
leaves of  Gongronema latifolium is a common remedy used in the treatment of  malaria in South Western Nigeria. 
Objective: To determine the antiplasmodial activities of  the combined herbal extracts and its impact on the haematological, 
hepatological and renological parameters in mice.
Methods: The 4-day suppressive and curative tests were used to assess the antiplasmodial activities of  the extract in mice 
infected with chloroquine-sensitive Plasmodium berghei at concentration of  200mg/kg, 400mg/kg and 800mg/kg body 
weight.  The haematological parameters including red blood cells, white blood cells, packed cell volume and haemoglobin 
count were analysed with an auto analyser. The activities of  alanine aminotransferase (ALT), aspartate aminotransferase 
(AST) and alkaline phosphatase (ALP) were determined, while urea, protein and creatinine were analysed by standard pro-
cedural methods.
Results: The 4-day suppressive test revealed that the test extract achieved percentage suppression of  39.0%, 41.6% and 
54.68% for the 200mg/kg, 400mg/kg and 800mg/kg concentration respectively. Additionally, the curative test achieved a 
high percentage suppression of  80.97%, 83.84% and 86.16% at the 200mg/kg, 400mg/kg and 800mg/kg concentration re-
spectively. The extracts did not induce significant change on haematological parameters (P>0.05), while significant elevation 
in the values of  the ALT and AST (P<0.05) was observed and elevation of  creatinine (P<0.05) at 800mg/kg. 
Conclusions: The results support the traditional use of  the herbal combination in the treatment of  malaria, however the 
liver cells were impacted by the extracts in bioassay conducted with mice.
Keywords: In vivo anti-plasmodial lime extract, Picralima nitida, Alstonia boonei, Gongronema latifolium, mice infected 
with chloroquine-sensitive plasmodium berghei.
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Background
Malaria is one of  the leading public health problems 
in many countries of  the world, especially in tropical 
and subtropical regions of  the world. An estimated 3.4 
billion people were at risk of  malaria in 20121. Nigeria 
accounts for a quarter of  all malaria cases in the World 
Health Organization African region2. 
Recently artemisinin has been widely used alone or in 
combination for malaria treatment. However, a major 
challenge of  resistance to these drugs by the Plasmodi-
um species has been a cardinal set back in the treatment 
of  the disease. The rapid emergence and widespread of  
resistance to all currently available antimalarials coupled 
with the fact that, the chloroquine resistance transport-
er gene has also been associated with increased suscep-
tibility to artemisinin, quinine and amodiaquine  calls 
for the development of  new potent antimalarials3. 
The search for novel potent antiplasmodial drugs has 
led to numerous investigations into traditional medici-
nal plants already used by local residents of  malaria en-
demic regions of  Africa and Asia4-7.
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In preparation of  herbal recipes for malaria therapy, a 
single plant or its combination with other plants could 
be used. The combination of  these different plants 
were claimed to cure and alleviate several ailments and 
dysfunctions in the body associated with malaria and it 
has been speculated that the active ingredients of  each 
plant in the preparation complemented one another 
in the fight against malaria parasite7. Plant combina-
tion used in South Western Nigeria includes: Alstonia 
boonei (bark), Mangifera indica (bark, leaves), Psid-
ium guajava (leaves), Carica papaya (leaves); Enantia 
Chlorantha (bark), Alstonia boonei (bark), Diospyros 
mespiliformis (bark); Ocimum gratissimum (Leaves), 
Anarcadium occidentale (foliage leaves), Lecaniodiscus 
cupanioides (foliage leaves), Curcuma longa (foliage 
leaves) and Citrus aurantifolia (foliage leaves)5. 
The use of  these traditional medicinal plants without 
specified accurate dosage and clear knowledge of  the 
toxic impacts of  their constituent compounds on body 
organs may be an impediment to the usage of  the plants 
despite the acclaimed efficacy. Ethanolic extracts of  
Clerodendrum violaceum leaves considerably reversed 
the alterations caused by malaria infection in liver and 
kidney function enzymes and is relatively non-toxic but 
significantly increased the level of  liver ALT8 and aque-
ous extracts of  Phyllantus amarus does not adversely 
affect the weight and the haematological parameters of  
Plasmodium berghei infected mice9.
Previous findings have identified seeds of  Picralima 
nitida10 and stem bark of  Alstonia boonei as having an-
tiplasmodial effects5, P. nitida leaves, roots, seeds and 
stem bark are also used by local traditional doctors for 
the treatment of  fever, hypertension, jaundice and gas-
trointestinal disorders11.
Alstonia boonei  is among the medicinal plants that 
have been widely used in recipes to treat malaria6,12. The 
stem bark of  this plant has been found to be effective in 
the treatment of  several diseases such as fever, painful 
micturition, insomnia, chronic diarrhea and has, rheu-
matic anti-inflammatory, antipyretic and analgesic prop-
erties13-14. 
Gongronema latifolium is widely employed in Nigeria 
for various medicinal and nutritional purposes15,16. Its 
hypoglycaemic, cardio-protective, hypolipidaemic, an-
ti-inflammatory and antioxidative properties  have been 
reported17-18.  In addition it  has been reported to exhib-
it strong antiplasmodic and bactericidal activities19.
One of  the locally available combinations of  medic-
inal plants employed in the chemotherapy of  malaria 
in South Western Nigeria is made from different parts 
of  these three different medicinal plants, these include 
seeds of  Picralima nitida, stem bark of  Alstonia boonei, 
leaves of  Gongronema latifolium soaked in Citrus au-
rantifolia (per com). Therefore, this study seeks to eval-
uate and establish the antiplasmodial activities as well as 
the suppressive and curative capacity of  the combined 
herbal extracts and also determine its impacts on the 
haematological, hepatological and renalogical parame-
ters in Plasmodium berghei infected mice.
Methods
Plant materials and extraction
The different part of  the four medicinal plants name-
ly the seeds of  Picralima nitida, stem bark of  Alstonia 
boonei, fresh leaves of  Gongronema latifolium were 
collected during the month of  September, 2013 in 
Awun Otta, OgunState, South West Nigeria. The identi-
fication and authentication was done by the Ethno-Sur-
vey Unit, Research and Training Department, Nigeria 
Natural Medicine Development Agency, Federal Min-
istry of  Science and Technology, Lagos. Specimens of  
the plant species were also deposited at the same centre.
All the specimen were cleaned with water and seeds of  
P. nitida were air-dried for two weeks, fresh leaves of  
G. latifolium were air dried for five days, while stem 
bark of  A. boonei were cut into small sizes and air dried 
for two weeks. Fresh juice from the fruits of  Citrus 
aurantifolium (lime) were collected from the matured 
fruits after cutting and hand pressed to obtain the liquid 
which was then filtered to remove the seeds from the 
solvent. All the three different plant parts were ground-
ed to powder differently, and stored in different well 
sealed containers prior to extraction which was carried 
out at the Biochemistry Division laboratory, Nigerian 
Institute of  Medical Research (NIMR), Lagos, Nigeria.
The plant extracts were mixed together in a ratio of  2: 
2: 1; 4.2 grams of  P. nitida and A. boonei with 2.1 grams 
of  G. latifolium mixed as a combined extract to form 
a total of  10.5 grams which is equivalent of  one table 
spoon full and mixed in a solution of  175ml lime juice.
The aqueous extract was kept in a well-sealed plastic 
container and stored in a refrigerator for three days 
to allow full extraction of  the active ingredients from 
the medicinal plants. On day 3, the preparation was fil-
ter-sterilized by passage through a 45m Millipore mem-
brane filter (St. Quentine, France) and the filtrate was 
utilized for the experiment.




0.5 grams or tablets of  Chloroquine phosphate, CQ 
(Emezor Pharma, Nigeria) was dissolved in 10ml Phos-
phate buffered saline (PBS) to final doses of  5mg/kg 
body weight. These served as positive control.
Animals
Fifty pure strains and adult Swiss albino mice with an 
average weight of  21g were obtained from the Animal 
house, NIMR, Yaba, Lagos. The animals were observed 
under 12 hours light/dark cycles in clean and well main-
tained cages in the Biochemistry laboratory of  NIMR. 
The rats were fed with mice pellets diet (Ladokun 
Farms, Ibadan Nigeria) and water ad libitium for one 
week so as to acclimatize to room temperature of  290 C. 
Preparation of  parasites and innoculum
A Chloroquine-sensitive Plasmodium berghei parasite 
which was obtained from the Biochemistry Division, 
NIMR, Lagos was used for the study. Test mice were 
infected with blood samples from the donor mice ob-
tained by ocular puncture, using a heparinized sterile 
capillary tube. The infected blood was diluted with 
phosphate buffer saline to enable innoculum of  0.1ml 
for each mouse which contains the required number 
of  parasitized red blood cell (106). The red blood cells 
(RBC) per unit volume was calculated based on the in-
noculum size. The normal number of  parasitized red 
blood cells was calculated by multiplying the percent 
of  parasitemia with the number of  red blood cells. The 
inoculated mice were then randomised into cages A, B, 
C, D and E, with each cage having 5 mice each. 
 
Antiplasmodial studies of  plant extracts
Suppressive treatment
The four day suppressive test20 was adopted for the 
study. Mice of  both sexes weighing (16-26g) which had 
been intraperitoneally infected with 106 erythrocytes 
in 0.1ml phosphate buffer saline were randomised into 
five groups, A, B, C, D and E with each group having 
five (5) animals each. Treatment of  animals started after 
2 hours on Day 0. Group A and B served as the con-
trol groups, while group C, D and E served as the test 
groups. Group A animals served as the negative control 
group. Group B animals were administered with 30mg/
kg of  chloroquine diphosphate which serves as the pos-
itive control group. In groups C, D and E, the infected 
animals were treated for four (4) days with doses of  
selected 200, 400 and 800mg/kg body weight with the 
filtered extracts of  the herbal combination through oral 
route using an oral canula. On day 4, thin films were 
made from the tail blood of  each mouse under aseptic 
conditions from 07:00 to 09:00am.  The blood smears 
were prepared by spreading the blood on a clean glass 
slide at angle 45 degrees, fixed with methanol, stained 
with 3% Giemsa stain for 45 minutes and examined 
with microscope under the oil immersion objective to 
determine the percentage parasiteamia microscopically 
(Olympus CX, Japan). This is necessary as to monitor 
the level of  percentage suppression which was then 
calculated. Death or mortality within 24 hours of  the 
herbal extraction administration was considered toxic 
to the animal.
The suppression of  parasitaemia in relation to the con-
trol was calculated using the recommended formula:
Average (Av) % suppression=
Av% parasitaemia in control – Av% parasitaemia in test    x 100
           
                  Av% parasitaemia in control
Curative treatment
The procedure of  Ryles and Peters was adopted for this 
study21. On day 0, twenty five (25) Swiss albino mice 
were grouped into five with each group having five an-
imals per cage based on body weight after standard in-
traperitoneal inoculation of  1 x 106 Plasmodium bergh-
ei infected red blood cell. All mice were inoculated with 
106 parasitized red blood cells in 0.1ml of  phosphate 
buffer saline. Group A with the least body weight were 
considered the negative control group and given dis-
tilled water. Group B animals which were selected as 
the positive control group were given a curative dose 
of  30mg/kg of  Chloroquine for three (3) days daily 
through oral canular. The other test groups, C, D and 
E were administered with the selected doses concen-
tration of  200mg, 400mg and 800mg/kg body weight 
(0.1ml, 0.2ml and 0.4ml) of  the prepared herbal extract 
for five days. Preparation of  thick blood film from the 
tail blood of  the animals commenced on the third day 
post inoculation, the herbal extract treatment adminis-
tration started on the same day and continued till day 
seven. Accordingly, the parasite density was calculated 
by counting the number of  parasite against 200 white 
blood cells (WBC) and multiplied by 8000. 
 
 
Determination of  haematological and biochemical 
parameters
On the fifth day of  post treatment, three mice each 
were removed from each group or cage, 5ml of  blood 
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was taken from the left eye (ocular) side of  the mice 
with micro haematocrit tubes through a 5ml pipe tubes. 
Two (2) mls of  blood was used for the haematological 
analysis. The haematological parameters analysed were 
Haeamoglobin count (Hb), White Blood Cell Count 
(WBC), Red Blood Cell Count (RBC) and Packed Cell 
Volume (PCV). The blood was analysed with the aid of  
an auto analyser (Minray Model BC 3200).
Three (3) mls of  the blood was used for biochemical 
analysis. A sample collected from each mouse was used 
for quantitative determination of  protein, alanine ami-
notransferase (ALT), aspartate aminotransferase (AST) 
and alkaline phosphatase (ALP), urea and creatinine. 
ALT and AST levels were measured with commercially 
available standard blood ALT and AST kits by Randox 
Reitman and Frankel ALT and AST level 2 controls 
(Cat. No. SC2643) respectively. The method of  Young22 
was employed in the ALP analysis. The plasma urea lev-
el was measured with commercially available standard 
blood urea kit by Biolabo, South Africa. The plasma 
creatinine level was measured with commercially avail-
able standard blood creatinine kit by standard protocol 
for photometric determination of  creatinine based on 
Jaffe kinetic method23. The Biuret method was used for 
the measurement of  protein level, while the Sulfanilic 




The result of  the study showed that the extract did not 
cause mortality within 24 hrs at all doses, as death was 
only witnessed in the negative control on the third day 
of  treatment. All the mice were physically active, except 
in the negative control. Gross physical and behaviour-
al observations of  the experimental mice also revealed 
no visible signs of  acute toxicity like trembling, loss of  
hair, loss of  appetite and reduction in agility. 
 
Suppression of  parasitaemia
Significant reduction of  parasitaemia (P < 0.05) was 
observed in all groups of  mice treated with the herb-
al extract when compared to the negative control. The 
effects of  these combined herbal extract was signifi-
cant when compared with the negative control, while 
Chloroquine (30mg/kg) caused 100% suppression. The 
percentage suppression in the group of  animals treated 
with 200mg/kg was 39.0%, while the highest suppres-
sion (54.68%) was recorded in the group treated with 
the highest dose, that is 800mg/kg (Table1). Reduction 
of  the parasitaemia was dose dependent as suppression 
increases with increase in concentration of  the test ex-
tract. 
 Table 1: Suppressive assay of the combination of powdered seed of Picralima nitida, stem bark of 
Alstonia boonei and leaves of Gongronema latifolium in Plasmodium berghei infected mice. 
 
Treatment  Groups Dose (mg/kg) Parasitaemia count in 
thousand(Mean ± 
S.D) 






A ? 11.54 ± 2.67 - 
B 30            - 100 
        
C 200 7.04 ± 2.81 39.0 
D 400 6.74 ± 2.08 41.6 
E 800 5.23 ± 1.55 54.68 
 
  
Clearance of  parasitaemia
The results of  the study indicated that the test extract 
displayed a very potent antiplasmodial activity against P. 
berghei malaria parasite in vivo when given at doses of  
200, 400 and 800 mg/kg.  Although, the extract failed to 
totally clear the parasites, however a high level of  clear-
ance was achieved on the fourth day of  post infection. 
The average parasitaemia count (in thousands) on the 
fourth day of  post infection was 3.5±0.7, 1.9±8.0, and 
1.2±0.4 (Table 2). Percentage parasitaemia clearance 
was 80.97%, 83.84% and 86.16% for the 200, 400 and 
800mg/kg body weight respectively, (Figure 1) while 
that of  Chloroquine was 100%. 




 Figure 1: Percentage Suppressive of the combination of powdered seed of Picralima nitida, stem 
bark of Alstonia boonei and leaves of Gongronema latifolium in Plasmodium berghei infected mice 
Haematological and biochemical parameters
The heamatological examination revealed that there was 
significant reduction (P>0.05) in RBCs at all treatment 
doses. The WBC was only significant when compared 
Table 2: Curative assay (treatment) of the combination of powdered seeds of Picralima nitida, stem bark of 
Alstonia boonei and leaves of Gongronema latifolium in Plasmodium berghei infected mice. 
Treatment        Group        
Dose 
(mg/kg) 
Parasitaemia count for the Treatment days  (in thousands) 





 ? 56.06±55.9 54.9±24.5 50.9±14.5 55.2±16.9 55.7±11.3 




42.31±11.2 0 0 0 
       C 200 45.3±11.9 38.0±6.2 23.6±5.4 17.2±2.0 10.6±8.0 
D 400 36.4±12.9 30.6±6.8 21.9±3.8 16.8±3.6 9.0±0.7 
E 800 38.6±11.5 31.4±7.9 16.9±6.2 11.1±2.7 7.7±0.4 
  
with the positive control at 800mg/kg. There was no 
observed difference (P<0.05) in the Hb and PCV levels 
of  all the treated groups when compared to the nega-
tive control (Table 3).
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The biochemical examination revealed significant in-
crease in the levels of  AST, ALT and Urea (P>0.05), 
but no significant increase in the levels of  ALP and pro-
Table 3: Haematological evaluation of controls and Plasmodium berghei infected mice treated with 
combination of powdered seed of Picralima nitida, stem bark of Alstonia boonei and leaves of Gongronema 
latifolium. 
Parameters Control –ve Control +ve 200 mg/kg 400 mg/kg 800 mg/kg 
RBC 3.31±0.21 5.27±0.31 3.17±0.21* 3.43±0.59* 3.97±0.50* 
WBC 8000±721.0 8800±1216.55 12733±1026.0 7600±600 5133.33±901.85* 
PCV 30.67±1.52 38.33±2.52 27±3.0 28.67±4.4 32±2.65 
Hb 10.14±0.47 12.68±0.76 8.98±1.03 9.49±1.37 10.61±0.92 
RBC= Red blood cell, WBC= White blood cell, PCV=Packed cell volume, Hb=Haemoglobin,  
*=Significant difference 
tein (P<0.05) for all the doses of  the treatment groups. 
Creatinine level only showed significant difference at 
800mg/kg when compared to the control groups (Ta-
ble 4).
Table 4: Biochemical evaluation of controls and Plasmodium berghei infected mice treated with combination 
of powdered seed of Picralima nitida, stem bark of Alstonia boonei and leaves of Gongronema latifolium. 
Parameters Control –ve Control +ve 200 mg/kg 400 mg/kg 800 mg/kg 
AST( µ/L) 147.5±5.5 117±1.00 160±1.00* 182.5±3.5* 184±7.0* 
ALT (µ/L) 37±0.00 36±2.00 47±1.00* 45.5±1.5* 49.5±0.5* 
ALP (µ/L) 63.48±8.28 115.92±5.52 168.36±13.8 182.16±27.6 124.2±13.8 
Urea (mg/dl) 56.97±2.42 77.58±2.43 85.45±0.61* 86.66±1.82* 92.13±3.64* 
Creatinine 
(µmol/L) 
1.09±0.03 0.76±0.11 0.8±0.02 1.07±0.01 1.46±0.03* 
Protein (g/L) 30.9±0.40 34.75±2.39 33.09±2.33 36.67±1.4 35.54±0.4 
 
AST=Aspartate transaminase, ALT=Alanine transaminase, ALP=Alanine Phosphatase 
*=Significant difference  
  Discussion
The emergence of  Plasmodium falciparum multi-drug 
resistant malaria  and drug resistance to artemisinin-de-
rivatives and to other drug combination therapies makes 
the development of  new potent antimalarial drugs im-
perative. Traditional medicinal plants have proved to be 
rich sources of  new drugs coupled with the fact that 
antimalarial drugs in use presently were either obtained 
directly from plants or developed using chemical struc-
tures of  plant-derived compound as templates. The 
feasibility of  discovering new potent antimalarials from 
traditional medicinal plants is very promising.
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This study demonstrates the in vivo antiplasmodial ac-
tivities of  lime extract of  a combination of  powdered 
seeds of  P. nitida, stem bark of  A. boonei and fresh 
leaves of  G. Latifolia. Four day chemosuppresive test 
showed that the extract achieved moderate suppres-
sion of  the Plasmodium parasite in mice infected with 
P. berghei. Chemosuppression achieved in this study 
was dose dependent with chemosuppression rate of  
54.68% at the highest dose (800mg/kg). However, the 
percentage suppression achieved at 400mg/kg dosage 
was lower than the percentage suppression achieved by 
the ethanolic extract of  A. boonei alone as reported by 
some workers25. The low chemosuppression rate may 
be due to the antagonistic property of  some active con-
stituents of  the plants or due to the difference in the 
effectiveness of  the medium of  extract.
The 4-day curative test revealed that the extract has a 
considerable high antiplasmodial effect. The curative 
effect was also dose dependent, but with a very small 
change with increase in dosage. The curative effect 
of  the combined extract at 400mg/kg body weight 
(83.84%) was in the same range with that of  A. boonei 
extracts used alone (81.36%)25. This is in line with previ-
ous findings that have confirmed the antimalarial effect 
of  the three individual plants6,25. The antimalarial activi-
ty of  the extracts could be attributed to the presence of  
some phytochemicals like alkaloids, tannins, saponins, 
flavonoids and terpenes present in the three plants used 
in the study. Specifically, the parasitaemia suppression 
effect of  the extract may be attributed to the presence 
of  alkaloids26.
An assessment of  the impact of  the extract on the 
haematological parameters showed marked difference 
(p<0.05) in the RBCs and WBCs (mg/kg) when com-
pared with the positive control, but no difference when 
compared with the negative control. The RBC count in-
creased with increase in the dose. It can be deduced that 
the significant reduction is not due to the impact of  the 
extracts, but probably to the impact of  the parasiteamia 
as reflected in the similarity in result for the negative 
control and the experimental mice. This could be eas-
ily explained with the fact that Plasmodium is known 
to colonise and lead to reduction in the RBCs and the 
reduction in WBCs which is similar to earlier38, this was 
probably due to the fact that most of  the WBCs have 
been deployed and used up in the immune response of  
the body to the introduction of  the parasitemia. Addi-
tionally, there was no significant change in the PCV and 
heamoglobin levels of  the test groups. This is line with 
earlier findings on some other traditional plants8. 
The AST and ALT level increased with increase in the 
dose of  the extract. There was significant difference in 
the value of  the experimental animals when compared 
with the two controls, providing sufficient evidence that 
the impact was due to the extract. This has also been 
reported in earlier findings on other traditional medici-
nal plants such as Chrozophora senegalenesis28 and eth-
anolic extract of  Magnifera indica29. The level of  the 
ALP showed no difference in all the experimental ani-
mals, suggesting that the leakage in AST and ALT was 
from the liver and not bile duct. Considering the obser-
vation in the three parameters, it can be adduced that 
the extract had an impact on the liver, thereby allowing 
a leakage of  AST and ALT into the blood stream.
 
The plasma protein showed no significant difference. 
However, urea level significantly increased with increase 
in dosage, while creatinine showed significant difference 
(p<0.05) only at the highest dose (800mg/kg). Protein 
level is a good indicator of  renal malfunction, but also 
elevated levels of  creatinine and urea are sound indi-
cators of  deficiency in renal function30 This suggests 
a mild damage to the kidney which may become acute 
at higher doses and with prolonged use. The damage is 
assumed to be mild because urea levels do not reflect 
the performance of  the kidneys like creatinine. This is 
because urea production is also affected by dehydration, 
food intake and tissue catabolism30. Histological exam-
ination may however be used to clearly establish renal 
malfunction.  
The increase in the incidence of  resistance to current 
antimalarials coupled with the spread of  fake antima-
larials makes the development of  traditional medicinal 
plant the most probable short term sustainable solution 
to malaria treatment.  Locally used medicinal plants can 
be fully assessed to establish their potency and also de-
termine their prospect as sources of  new antimalarial 
agents. Further work is suggested to characterize the 
active ingredients and to establish a full risk profile of  
the combined plant extracts.
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